TCOV
NVAX icon

Trust Company of Vermont’s Novavax NVAX Stock Holding History

Trust Company of Vermont’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20
Closed -$2K – 783
2020
Q4 		$2K Hold
20
– – ﹤0.01% 721
2020
Q3 		$2K Hold
20
– – ﹤0.01% 706
2020
Q2 		$2K Buy
+20
New +$765 ﹤0.01% 728

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trust Company of Vermont's NVAX Position: Q1 2021 in Review

Trust Company of Vermont sold out of Novavax (NVAX) in Q1 2021, closing a stake of 20 shares — an estimated $2K sold.

Trust Company of Vermont first reported a position in NVAX in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 390 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Trust Company of Vermont reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • Trust Company of Vermont sold 20 Novavax shares in Q1 2021, an estimated $2K.
  • Trust Company of Vermont first reported a position in Novavax in Q2 2020 and held it in 3 quarters.
  • Trust Company of Vermont's Novavax position peaked at $2K in Q4 2020.
  • 390 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Trust Company of Vermont's 13F filing for Q1 2021, filed 16 Apr 2021.